Actelion’s Flolan Generic Outstrips Originator in Pediatric Use with Rare Dosage Nod; Japan Chief Says Company Fulfilling Maker’s Responsibility

In a rare move, Actelion Pharmaceuticals Japan received approval last month for a pediatric dosage of its generic version of the pulmonary arterial hypertension (PAH) treatment Flolan (epoprostenol sodium), which is not carried by the original drug marketed by GlaxoSmithKline...read more